Theriva Biologics Inc TOVX Shares are trading 15% lower at $0.17 on Monday morning after the company announced a 1-for-25 reverse stock split.

This reverse stock split will be effective on August 26. At the market open on that day, the Company’s common stock will begin trading on a split-adjusted basis.

The reverse stock split was approved by the Company’s Board of Directors on August 15. As a result of this reverse stock split, the number of common shares outstanding will be significantly reduced from 25,131,230 to 1,005,249, not including fractional shares.

The purpose of this reverse stock split is to ensure that the company meets the price per share requirements. NYSE American.

Also read: Markets in Asia (excluding Japan) rise, Europe opens in the green, Gold hits new high as dollar weakens – Global markets today while the US slept

Should I sell my TOVX shares?

Whether to sell or hold a stock depends largely on the investor’s strategy and risk tolerance. Swing traders may sell an outperforming stock to realize a capital gain, while long-term investors may ride out the turbulence in anticipation of further price appreciation.

Similarly, traders who want to minimize their losses may want to sell a stock when it falls by a certain percentage. Long-term investors, on the other hand, may see this as an opportunity to buy more shares at a discounted price.

Theriva Biologics shares have lost 61.44% year-to-date. This compares to an average annual return of -64.04%, which means the stock has outperformed its historical averages. Investors can compare a stock’s performance with its historical performance to assess whether it is a normal development or a potential trading opportunity.

For analytical tools, chart data, and access to exclusive stock news, check out Benzinga PRO. Try it free.

TOVX has a 52-week high of $0.68 and a 52-week low of $0.18.